指南与共识产科母胎医学

新Delphi共识定义下16、20或30周诊断的选择性胎儿生长受限的单绒毛膜双羊膜囊双胎妊娠结局

Outcome of monochorionic twin pregnancy with selective fetal growth restriction at 16, 20 or 30 weeks according to new Delphi consensus definition.
指南 / 共识 · Ultrasound Obstet Gynecol · 2020-01-01

这项回顾性队列研究纳入675例单绒毛膜双羊膜囊双胎妊娠,按新Delphi共识标准在16、20或30周诊断选择性胎儿生长受限(sFGR)共177例(26%)。总体生存率为88%(313/354),双胎存活占82%,单胎存活占12%,双胎丢失占6%。后续发生TTTS、II型或III型sFGR及至少一胎重大畸形与生存率降低独立相关,而诊断孕周并非独立预测因素。

要点

  • 孤立性sFGR(无后续TAPS或TTTS)生存率达91%,总体sFGR生存率为88%。
  • II型sFGR生存率仅55%,显著低于I型的96%和III型的83%。
  • 后续发生TTTS者生存率65%,显著低于孤立性sFGR的91%。

核心结论

  • 孤立性sFGR的单绒毛膜双羊膜囊双胎妊娠生存率约为90%。
  • 后续发生TTTS、小胎脐动脉舒张末期血流缺失或反向以及至少一胎重大畸形会降低sFGR的生存率。
  • 首次诊断孕周并非生存率的独立预测因素。

研究设计与样本

  • 回顾性研究,纳入从早孕期开始随访的单绒毛膜双羊膜囊双胎妊娠,在16、20或30周根据新Delphi共识标准诊断sFGR。
  • 共分析675例妊娠,其中177例(26%)诊断为sFGR。
  • 采用单因素和多因素广义估计方程模型分析生存预测因素。

主要发现

  • 总体生存率(至出生后28天)为313/354(88%);双胎存活146/177(82%),单胎存活21/177(12%),双胎丢失10/177(6%)。
  • 后续发生TAPS者6/177(3%),发生TTTS者17/177(10%);所有TAPS胎儿均存活。
  • sFGR后续发生TTTS者生存率65%(22/34),孤立性sFGR生存率91%(279/308)(P < 0.001)。
  • I型sFGR占110/177(62%),生存率96%(212/220);II型生存率55%(12/22)(P < 0.001);III型生存率83%(55/66)(P = 0.006)。
  • 早发型(16或20周首次诊断)占130/177(73%),生存率85%(221/260);晚发型(30周首次诊断)生存率98%(92/94)(P = 0.04)。

关键数值与推荐

  • sFGR定义(新Delphi共识):一胎估计胎儿体重(EFW)< 第3百分位,或满足以下至少两项:一胎EFW < 第10百分位、一胎腹围 < 第10百分位、EFW不一致 ≥ 25%、较小胎脐动脉搏动指数 > 第95百分位。
  • 与生存率降低独立相关的因素:后续发生TTTS(OR 0.18,95%CI 0.06-0.52)、II型sFGR(OR 0.06,95%CI 0.02-0.24)、III型sFGR(OR 0.21,95%CI 0.07-0.60)、至少一胎重大畸形(OR 0.12,95%CI 0.04-0.34)。
  • 首次诊断孕周并非独立相关因素。

临床怎么用

  • 对单绒毛膜双羊膜囊双胎按新Delphi共识标准筛查sFGR,并注意分型(I、II、III型)。
  • 诊断sFGR后应密切监测是否后续发生TTTS和TAPS,因其显著影响生存率。
  • 合并重大畸形或II型sFGR时,应向患者说明生存率显著降低。

局限性

  • 本研究为回顾性设计。
  • 摘要未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report the outcome of selective fetal growth restriction (sFGR) diagnosed according to the new Delphi consensus definition, and determine potential predictors of survival, in a cohort of unselected monochorionic diamniotic twin pregnancies. METHODS: This was a retrospective study of monochorionic diamniotic twin pregnancies followed from the first trimester onward, which were diagnosed with sFGR at 16, 20 or 30 weeks' gestation. sFGR was defined according to the new Delphi consensus criteria as presence of either an estimated fetal weight (EFW) < 3rd centile in one twin or at least two of the following: EFW of one twin < 10th centile, abdominal circumference of one twin < 10th centile, EFW discordance ≥ 25% or umbilical artery pulsatility index of the smaller twin > 95th centile. The primary outcomes were the overall survival rate (up to day 28 after birth) and risk of loss of one or both twins. We further determined possible predictors of survival using uni- and multivariate generalized estimated equation modeling. RESULTS: We analyzed 675 pregnancies, of which 177 (26%) were diagnosed with sFGR at 16, 20 or 30 weeks. The overall survival rate was 313/354 (88%) with 146/177 (82%) pregnancies resulting in survival of both twins, 21/177 (12%) in survival of one twin and 10/177 (6%) in loss of both twins. Subsequent twin anemia-polycythemia sequence (TAPS) developed in 6/177 (3%) and twin-twin transfusion syndrome (TTTS) in 17/177 (10%) pregnancies. All TAPS fetuses survived. The survival rate in sFGR pregnancies that subsequently developed TTTS was 65% (22/34), compared with 91% (279/308) in those with isolated sFGR (no subsequent TAPS or TTTS) (P < 0.001). The majority of sFGR cases were Type I (110/177 (62%)) and had a survival rate of 96% (212/220), as compared with a survival of 55% (12/22) in those with Type-II (P < 0.001) and 83% (55/66) in those with Type-III (P = 0.006) sFGR. The majority of sFGR pregnancies (130/177 (73%)) were first diagnosed at 16 or 20 weeks (early onset), with a survival rate of 85% (221/260), as compared with a survival of 98% (92/94) in sFGR first diagnosed at 30 weeks (late onset) (P = 0.04). A major anomaly in at least one twin was present in 28/177 (16%) sFGR cases. In these pregnancies, survival was 39/56 (70%), compared with 274/298 (92%) in those without an anomaly (P < 0.001). Subsequent development of TTTS (odds ratio (OR), 0.18 (95% CI, 0.06-0.52)), Type-II sFGR (OR, 0.06 (95% CI, 0.02-0.24)) and Type-III sFGR (OR, 0.21 (95% CI, 0.07-0.60)) and presence of a major anomaly in at least one twin (OR, 0.12 (95% CI, 0.04-0.34)), but not gestational age at first diagnosis, were independently associated with decreased survival. CONCLUSIONS: Isolated sFGR is associated with a 90% survival rate in monochorionic diamniotic twin pregnancies. The subsequent development of TTTS, absent or reversed end-diastolic flow in the umbilical artery of the smaller twin and the presence of a major anomaly adversely affect survival in sFGR. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Couck I, Ponnet S, Deprest J, et al. Outcome of monochorionic twin pregnancy with selective fetal growth restriction at 16, 20 or 30 weeks according to new Delphi consensus definition. Ultrasound Obstet Gynecol. 2020. PMID: 31945801. doi:10.1002/uog.21975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。